---
title: Colchicine in Acute Myocardial Infarction
date: '2024-11-18'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39555823/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&fc=20211015124055&ff=20241119173555&v=2.18.0.post9+e462414
source: N Engl J Med
description: 'CONCLUSIONS: Among patients who had myocardial infarction, treatment
  with colchicine, when started soon after myocardial infarction and continued for
  a median of 3 years, did not reduce the incidence of the composite primary outcome
  (death from cardiovascular causes, recurrent myocardial infarction, stroke, or unplanned
  ischemia-driven coronary revascularization). (Funded by the Canadian Institutes
  of Health Research and others; CLEAR ClinicalTrials.gov number, ...'
disable_comments: true
---
CONCLUSIONS: Among patients who had myocardial infarction, treatment with colchicine, when started soon after myocardial infarction and continued for a median of 3 years, did not reduce the incidence of the composite primary outcome (death from cardiovascular causes, recurrent myocardial infarction, stroke, or unplanned ischemia-driven coronary revascularization). (Funded by the Canadian Institutes of Health Research and others; CLEAR ClinicalTrials.gov number, ...